AYBARION TRADEEU trade movers · 2026-03 · chapter 30
EU trade movers: March 2026, Pharmaceutical products
The largest month on month and year on year changes in the trade of each EU member state with each partner country, per HS4 product in chapter 30. Flows of at least EUR 5 million in March 2026; percent lists need at least EUR 1 million in the comparison month. Every figure carries its Eurostat record ID.
February 2026 · April 2026 · All chapters, March 2026 · Atom feed
Largest month on month changes, EUR
| # | Flow | Product | March 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Slovenia exports to Switzerland | 3004 Medicaments | EUR 2.4 billion | EUR 1.5 billion 2026-02 | +EUR 925.9 million | +60.9% | DS-045409:SI:CH:3004:2:2026-03 DS-045409:SI:CH:3004:2:2026-02 |
| 2 | Slovenia imports from Switzerland | 3004 Medicaments | EUR 1.2 billion | EUR 420.0 million 2026-02 | +EUR 810.0 million | +192.8% | DS-045409:SI:CH:3004:1:2026-03 DS-045409:SI:CH:3004:1:2026-02 |
| 3 | Belgium imports from Ireland | 3003 Medicaments | EUR 602.9 million | EUR 11.5 million 2026-02 | +EUR 591.4 million | +5,145.2% | DS-045409:BE:IE:3003:1:2026-03 DS-045409:BE:IE:3003:1:2026-02 |
| 4 | Netherlands imports from Denmark | 3002 Human blood | EUR 8.3 million | EUR 553.1 million 2026-02 | −EUR 544.8 million | −98.5% | DS-045409:NL:DK:3002:1:2026-03 DS-045409:NL:DK:3002:1:2026-02 |
| 5 | Ireland exports to Belgium | 3003 Medicaments | EUR 547.1 million | EUR 2.7 million 2026-02 | +EUR 544.3 million | +20,092.0% | DS-045409:IE:BE:3003:2:2026-03 DS-045409:IE:BE:3003:2:2026-02 |
| 6 | Italy exports to United States | 3002 Human blood | EUR 1.2 billion | EUR 726.9 million 2026-02 | +EUR 501.2 million | +69.0% | DS-045409:IT:US:3002:2:2026-03 DS-045409:IT:US:3002:2:2026-02 |
| 7 | Ireland imports from Italy | 3004 Medicaments | EUR 181.5 million | EUR 587.3 million 2026-02 | −EUR 405.8 million | −69.1% | DS-045409:IE:IT:3004:1:2026-03 DS-045409:IE:IT:3004:1:2026-02 |
| 8 | Belgium imports from Ireland | 3002 Human blood | EUR 244.5 million | EUR 515.8 million 2026-02 | −EUR 271.3 million | −52.6% | DS-045409:BE:IE:3002:1:2026-03 DS-045409:BE:IE:3002:1:2026-02 |
| 9 | Ireland imports from Germany | 3003 Medicaments | EUR 278.3 million | EUR 8.2 million 2026-02 | +EUR 270.1 million | +3,283.8% | DS-045409:IE:DE:3003:1:2026-03 DS-045409:IE:DE:3003:1:2026-02 |
| 10 | Italy imports from Netherlands | 3002 Human blood | EUR 137.7 million | EUR 403.7 million 2026-02 | −EUR 266.1 million | −65.9% | DS-045409:IT:NL:3002:1:2026-03 DS-045409:IT:NL:3002:1:2026-02 |
| 11 | Ireland exports to United States | 3002 Human blood | EUR 1.3 billion | EUR 1.0 billion 2026-02 | +EUR 254.0 million | +25.2% | DS-045409:IE:US:3002:2:2026-03 DS-045409:IE:US:3002:2:2026-02 |
| 12 | Italy imports from China | 3004 Medicaments | EUR 405.3 million | EUR 655.8 million 2026-02 | −EUR 250.5 million | −38.2% | DS-045409:IT:CN:3004:1:2026-03 DS-045409:IT:CN:3004:1:2026-02 |
| 13 | Ireland exports to Belgium | 3002 Human blood | EUR 223.8 million | EUR 472.3 million 2026-02 | −EUR 248.6 million | −52.6% | DS-045409:IE:BE:3002:2:2026-03 DS-045409:IE:BE:3002:2:2026-02 |
| 14 | Belgium exports to United States | 3004 Medicaments | EUR 392.4 million | EUR 615.0 million 2026-02 | −EUR 222.6 million | −36.2% | DS-045409:BE:US:3004:2:2026-03 DS-045409:BE:US:3004:2:2026-02 |
| 15 | Italy exports to France | 3004 Medicaments | EUR 401.6 million | EUR 195.1 million 2026-02 | +EUR 206.5 million | +105.8% | DS-045409:IT:FR:3004:2:2026-03 DS-045409:IT:FR:3004:2:2026-02 |
Largest month on month changes, percent
| # | Flow | Product | March 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland exports to Belgium | 3003 Medicaments | EUR 547.1 million | EUR 2.7 million 2026-02 | +EUR 544.3 million | +20,092.0% | DS-045409:IE:BE:3003:2:2026-03 DS-045409:IE:BE:3003:2:2026-02 |
| 2 | Belgium imports from Ireland | 3003 Medicaments | EUR 602.9 million | EUR 11.5 million 2026-02 | +EUR 591.4 million | +5,145.2% | DS-045409:BE:IE:3003:1:2026-03 DS-045409:BE:IE:3003:1:2026-02 |
| 3 | Ireland imports from Germany | 3003 Medicaments | EUR 278.3 million | EUR 8.2 million 2026-02 | +EUR 270.1 million | +3,283.8% | DS-045409:IE:DE:3003:1:2026-03 DS-045409:IE:DE:3003:1:2026-02 |
| 4 | France imports from China | 3004 Medicaments | EUR 73.1 million | EUR 2.7 million 2026-02 | +EUR 70.4 million | +2,601.8% | DS-045409:FR:CN:3004:1:2026-03 DS-045409:FR:CN:3004:1:2026-02 |
| 5 | Germany imports from Finland | 3004 Medicaments | EUR 60.5 million | EUR 3.8 million 2026-02 | +EUR 56.6 million | +1,482.3% | DS-045409:DE:FI:3004:1:2026-03 DS-045409:DE:FI:3004:1:2026-02 |
| 6 | Ireland exports to Japan | 3002 Human blood | EUR 169.7 million | EUR 11.6 million 2026-02 | +EUR 158.1 million | +1,366.0% | DS-045409:IE:JP:3002:2:2026-03 DS-045409:IE:JP:3002:2:2026-02 |
| 7 | Finland exports to Germany | 3004 Medicaments | EUR 60.6 million | EUR 5.4 million 2026-02 | +EUR 55.2 million | +1,025.7% | DS-045409:FI:DE:3004:2:2026-03 DS-045409:FI:DE:3004:2:2026-02 |
| 8 | Sweden exports to China | 3002 Human blood | EUR 23.4 million | EUR 2.1 million 2026-02 | +EUR 21.3 million | +1,012.4% | DS-045409:SE:CN:3002:2:2026-03 DS-045409:SE:CN:3002:2:2026-02 |
| 9 | Finland exports to China | 3004 Medicaments | EUR 25.8 million | EUR 2.4 million 2026-02 | +EUR 23.4 million | +973.4% | DS-045409:FI:CN:3004:2:2026-03 DS-045409:FI:CN:3004:2:2026-02 |
| 10 | Italy imports from Netherlands | 3003 Medicaments | EUR 23.3 million | EUR 2.4 million 2026-02 | +EUR 20.9 million | +877.8% | DS-045409:IT:NL:3003:1:2026-03 DS-045409:IT:NL:3003:1:2026-02 |
| 11 | Greece imports from Ireland | 3004 Medicaments | EUR 38.9 million | EUR 4.0 million 2026-02 | +EUR 34.9 million | +863.5% | DS-045409:GR:IE:3004:1:2026-03 DS-045409:GR:IE:3004:1:2026-02 |
| 12 | Italy exports to Russia | 3004 Medicaments | EUR 133.0 million | EUR 15.4 million 2026-02 | +EUR 117.6 million | +762.7% | DS-045409:IT:RU:3004:2:2026-03 DS-045409:IT:RU:3004:2:2026-02 |
| 13 | Ireland exports to Greece | 3004 Medicaments | EUR 46.0 million | EUR 5.6 million 2026-02 | +EUR 40.4 million | +726.8% | DS-045409:IE:GR:3004:2:2026-03 DS-045409:IE:GR:3004:2:2026-02 |
| 14 | Poland imports from Switzerland | 3002 Human blood | EUR 37.3 million | EUR 4.6 million 2026-02 | +EUR 32.6 million | +704.0% | DS-045409:PL:CH:3002:1:2026-03 DS-045409:PL:CH:3002:1:2026-02 |
| 15 | Germany exports to Slovenia | 3002 Human blood | EUR 31.8 million | EUR 4.1 million 2026-02 | +EUR 27.7 million | +683.9% | DS-045409:DE:SI:3002:2:2026-03 DS-045409:DE:SI:3002:2:2026-02 |
Largest year on year changes, EUR
| # | Flow | Product | March 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland imports from Germany | 3004 Medicaments | EUR 84.6 million | EUR 1.4 billion 2025-03 | −EUR 1.3 billion | −94.0% | DS-045409:IE:DE:3004:1:2026-03 DS-045409:IE:DE:3004:1:2025-03 |
| 2 | Germany exports to United States | 3004 Medicaments | EUR 810.7 million | EUR 2.0 billion 2025-03 | −EUR 1.2 billion | −59.2% | DS-045409:DE:US:3004:2:2026-03 DS-045409:DE:US:3004:2:2025-03 |
| 3 | Ireland exports to United States | 3004 Medicaments | EUR 599.0 million | EUR 1.6 billion 2025-03 | −EUR 985.9 million | −62.2% | DS-045409:IE:US:3004:2:2026-03 DS-045409:IE:US:3004:2:2025-03 |
| 4 | Netherlands imports from Ireland | 3002 Human blood | EUR 1.4 billion | EUR 543.6 million 2025-03 | +EUR 897.0 million | +165.0% | DS-045409:NL:IE:3002:1:2026-03 DS-045409:NL:IE:3002:1:2025-03 |
| 5 | Ireland exports to Netherlands | 3002 Human blood | EUR 1.4 billion | EUR 672.5 million 2025-03 | +EUR 719.0 million | +106.9% | DS-045409:IE:NL:3002:2:2026-03 DS-045409:IE:NL:3002:2:2025-03 |
| 6 | Belgium exports to United States | 3002 Human blood | EUR 680.6 million | EUR 1.4 billion 2025-03 | −EUR 709.1 million | −51.0% | DS-045409:BE:US:3002:2:2026-03 DS-045409:BE:US:3002:2:2025-03 |
| 7 | Ireland exports to United States | 3002 Human blood | EUR 1.3 billion | EUR 1.9 billion 2025-03 | −EUR 594.2 million | −32.0% | DS-045409:IE:US:3002:2:2026-03 DS-045409:IE:US:3002:2:2025-03 |
| 8 | Belgium imports from Ireland | 3003 Medicaments | EUR 602.9 million | EUR 12.0 million 2025-03 | +EUR 591.0 million | +4,944.3% | DS-045409:BE:IE:3003:1:2026-03 DS-045409:BE:IE:3003:1:2025-03 |
| 9 | Slovenia imports from Switzerland | 3004 Medicaments | EUR 1.2 billion | EUR 682.4 million 2025-03 | +EUR 547.6 million | +80.3% | DS-045409:SI:CH:3004:1:2026-03 DS-045409:SI:CH:3004:1:2025-03 |
| 10 | Ireland exports to Belgium | 3003 Medicaments | EUR 547.1 million | EUR 11.0 million 2025-03 | +EUR 536.0 million | +4,851.6% | DS-045409:IE:BE:3003:2:2026-03 DS-045409:IE:BE:3003:2:2025-03 |
| 11 | Slovenia exports to Switzerland | 3002 Human blood | EUR 76.8 million | EUR 569.7 million 2025-03 | −EUR 492.9 million | −86.5% | DS-045409:SI:CH:3002:2:2026-03 DS-045409:SI:CH:3002:2:2025-03 |
| 12 | Belgium imports from United States | 3004 Medicaments | EUR 534.3 million | EUR 989.7 million 2025-03 | −EUR 455.4 million | −46.0% | DS-045409:BE:US:3004:1:2026-03 DS-045409:BE:US:3004:1:2025-03 |
| 13 | Netherlands exports to United States | 3004 Medicaments | EUR 61.0 million | EUR 501.1 million 2025-03 | −EUR 440.1 million | −87.8% | DS-045409:NL:US:3004:2:2026-03 DS-045409:NL:US:3004:2:2025-03 |
| 14 | Belgium imports from Ireland | 3004 Medicaments | EUR 77.8 million | EUR 483.3 million 2025-03 | −EUR 405.5 million | −83.9% | DS-045409:BE:IE:3004:1:2026-03 DS-045409:BE:IE:3004:1:2025-03 |
| 15 | Ireland exports to Belgium | 3004 Medicaments | EUR 109.2 million | EUR 466.4 million 2025-03 | −EUR 357.2 million | −76.6% | DS-045409:IE:BE:3004:2:2026-03 DS-045409:IE:BE:3004:2:2025-03 |
Largest year on year changes, percent
| # | Flow | Product | March 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Finland exports to United States | 3004 Medicaments | EUR 162.5 million | EUR 1.4 million 2025-03 | +EUR 161.1 million | +11,809.1% | DS-045409:FI:US:3004:2:2026-03 DS-045409:FI:US:3004:2:2025-03 |
| 2 | Belgium imports from Ireland | 3003 Medicaments | EUR 602.9 million | EUR 12.0 million 2025-03 | +EUR 591.0 million | +4,944.3% | DS-045409:BE:IE:3003:1:2026-03 DS-045409:BE:IE:3003:1:2025-03 |
| 3 | Ireland exports to Belgium | 3003 Medicaments | EUR 547.1 million | EUR 11.0 million 2025-03 | +EUR 536.0 million | +4,851.6% | DS-045409:IE:BE:3003:2:2026-03 DS-045409:IE:BE:3003:2:2025-03 |
| 4 | Ireland imports from Germany | 3003 Medicaments | EUR 278.3 million | EUR 7.7 million 2025-03 | +EUR 270.6 million | +3,495.9% | DS-045409:IE:DE:3003:1:2026-03 DS-045409:IE:DE:3003:1:2025-03 |
| 5 | Denmark exports to Sweden | 3004 Medicaments | EUR 90.7 million | EUR 2.8 million 2025-03 | +EUR 87.9 million | +3,181.0% | DS-045409:DK:SE:3004:2:2026-03 DS-045409:DK:SE:3004:2:2025-03 |
| 6 | Denmark exports to Czechia | 3004 Medicaments | EUR 19.7 million | EUR 1.1 million 2025-03 | +EUR 18.6 million | +1,665.0% | DS-045409:DK:CZ:3004:2:2026-03 DS-045409:DK:CZ:3004:2:2025-03 |
| 7 | Denmark exports to Finland | 3004 Medicaments | EUR 20.8 million | EUR 1.2 million 2025-03 | +EUR 19.6 million | +1,633.6% | DS-045409:DK:FI:3004:2:2026-03 DS-045409:DK:FI:3004:2:2025-03 |
| 8 | Poland imports from Switzerland | 3002 Human blood | EUR 37.3 million | EUR 2.8 million 2025-03 | +EUR 34.5 million | +1,238.8% | DS-045409:PL:CH:3002:1:2026-03 DS-045409:PL:CH:3002:1:2025-03 |
| 9 | Greece imports from Ireland | 3004 Medicaments | EUR 38.9 million | EUR 3.0 million 2025-03 | +EUR 36.0 million | +1,203.9% | DS-045409:GR:IE:3004:1:2026-03 DS-045409:GR:IE:3004:1:2025-03 |
| 10 | France exports to Canada | 3002 Human blood | EUR 15.6 million | EUR 1.3 million 2025-03 | +EUR 14.3 million | +1,085.8% | DS-045409:FR:CA:3002:2:2026-03 DS-045409:FR:CA:3002:2:2025-03 |
| 11 | Belgium imports from Singapore | 3004 Medicaments | EUR 206.7 million | EUR 17.5 million 2025-03 | +EUR 189.2 million | +1,084.1% | DS-045409:BE:SG:3004:1:2026-03 DS-045409:BE:SG:3004:1:2025-03 |
| 12 | Latvia imports from France | 3004 Medicaments | EUR 11.5 million | EUR 1.0 million 2025-03 | +EUR 10.5 million | +1,037.5% | DS-045409:LV:FR:3004:1:2026-03 DS-045409:LV:FR:3004:1:2025-03 |
| 13 | Italy imports from Netherlands | 3003 Medicaments | EUR 23.3 million | EUR 2.2 million 2025-03 | +EUR 21.1 million | +965.2% | DS-045409:IT:NL:3003:1:2026-03 DS-045409:IT:NL:3003:1:2025-03 |
| 14 | Sweden exports to Taiwan | 3004 Medicaments | EUR 18.8 million | EUR 1.8 million 2025-03 | +EUR 17.0 million | +957.7% | DS-045409:SE:TW:3004:2:2026-03 DS-045409:SE:TW:3004:2:2025-03 |
| 15 | Italy exports to Kuwait | 3004 Medicaments | EUR 14.3 million | EUR 1.6 million 2025-03 | +EUR 12.7 million | +799.2% | DS-045409:IT:KW:3004:2:2026-03 DS-045409:IT:KW:3004:2:2025-03 |
Data Passport
- Eurostat Comext DS-045409: monthly trade of the EU member states by partner country and product, EUR and net mass, months 2026-02, 2026-03 and 2025-03. Licence: Eurostat reuse policy, free reuse with attribution "Source: Eurostat" (© European Union). Record IDs: DS-045409:reporter:partner:product:flow:month. Source
- Method: For each EU reporter, HS4 product, partner country and flow, the value of March 2026 is compared with the month before and with the same month a year earlier. A missing month row counts as no recorded trade. Lists rank by the absolute change in EUR or by the percent change; aggregates (world, intra and extra EU) and confidential partners are left out, as are Peru and the Philippines.
Trade database built 2026-10-24. Values are official statistics as published; nothing on this page is estimated or invented. More in our methodology.
See the companies
Members see the importers and exporters behind these flows, with their evidence and Data Passport.